BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8060550)

  • 1. The changing spectrum of AIDS index diseases in Canada.
    Montaner JS; Le T; Hogg R; Ricketts M; Sutherland D; Strathdee SA; O'Shaughnessy M; Schechter MT
    AIDS; 1994 May; 8(5):693-6. PubMed ID: 8060550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
    Dore GJ; Hoy JF; Mallal SA; Li Y; Mijch AM; French MA; Cooper DA; Kaldor JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):39-43. PubMed ID: 9377123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
    Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS.
    Chan IS; Neaton JD; Saravolatz LD; Crane LR; Osterberger J
    AIDS; 1995 Oct; 9(10):1145-51. PubMed ID: 8519450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
    Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
    AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.
    Michaels SH; Clark R; Kissinger P
    Clin Infect Dis; 1999 Aug; 29(2):468-9. PubMed ID: 10476778
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe opportunistic infections in AIDS patients with late-stage disease.
    Lifson AR; Olson R; Roberts SG; Poscher ME; Drew WL; Conant MA
    J Am Board Fam Pract; 1994; 7(4):288-91. PubMed ID: 7942097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change.
    Porter K; Fairley CK; Wall PG; Evans BG; Goldberg DJ; Weerasuriya M; Noone A
    Int J STD AIDS; 1996 Jul; 7(4):252-7. PubMed ID: 8876355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996.
    Pezzotti P; Serraino D; Rezza G; Dal Maso L; Vaccher E; Lepri AC; Franceschi S
    Int J Epidemiol; 1999 Oct; 28(5):975-81. PubMed ID: 10597999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of preventing AIDS-related opportunistic infections.
    Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
    JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary complications of HIV infection: autopsy findings.
    Afessa B; Green W; Chiao J; Frederick W
    Chest; 1998 May; 113(5):1225-9. PubMed ID: 9596298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study.
    Bacellar H; Muñoz A; Hoover DR; Phair JP; Besley DR; Kingsley LA; Vermund SH
    J Infect Dis; 1994 Nov; 170(5):1284-7. PubMed ID: 7963728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opportunistic infections in AIDS. The pulmonary manifestations].
    Scialpi M; Gius S; Branz F; Dalla Palma F
    Radiol Med; 1993; 85(1-2):40-8. PubMed ID: 8386841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
    Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
    AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opportunistic infections--prevention and treatment].
    Sidahora; 1995; ():42-7. PubMed ID: 11362439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of opportunistic infections among HIV-1 infected people in Hong Kong.
    Wong KH; Lee SS; Lo YC; Li PC; Ho HF; Sitt WH; Lam TW; Lai KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Feb; 55(2):127-36. PubMed ID: 7750052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.